Clinical Trials for Gan & Lee Pharmaceutical

Explore 16 clinical trials worldwide

Showing 1-16 of 16 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Gan & Lee Pharmaceutical

Clinical Trials (16)

NCT07128888
Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection
PHASE1Not yet recruiting
60 participants
Started: Nov 17, 2025 · Completed: Jul 5, 2026
1 condition1 sponsor1 location
NCT07193147
Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment
PHASE1Not yet recruiting
36 participants
Started: Oct 13, 2025 · Completed: Nov 4, 2026
1 condition1 sponsor1 location
NCT07165223
A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
PHASE3Not yet recruiting
300 participants
Started: Sep 28, 2025 · Completed: Nov 10, 2026
1 condition1 sponsor1 location
NCT07150975
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
PHASE3Not yet recruiting
420 participants
Started: Sep 15, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor0 locations
NCT07144098
Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver Function
PHASE1Recruiting
24 participants
Started: Aug 12, 2025 · Completed: Jan 26, 2027
1 condition1 sponsor1 location
NCT07055386
A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus
PHASE2Active, not recruiting
90 participants
Started: Jun 24, 2025 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT06974487
A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects
PHASE1Not yet recruiting
30 participants
Started: May 8, 2025 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT07119450
The Study of [14C] GZR18
PHASE1Active, not recruiting
6 participants
Started: May 7, 2025 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT07141030
Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal Function
PHASE1Recruiting
32 participants
Started: Apr 11, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06767748
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
PHASE3Recruiting
620 participants
Started: Feb 17, 2025 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06767761
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated with Basal + Prandial Insulin
PHASE3Not yet recruiting
580 participants
Started: Feb 14, 2025 · Completed: Apr 9, 2026
1 condition1 sponsor0 locations
NCT06767735
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects with Type 2 Diabetes Mellitus (T2DM)
PHASE3Not yet recruiting
580 participants
Started: Feb 14, 2025 · Completed: Aug 17, 2026
1 condition1 sponsor0 locations
NCT06777238
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects with Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise
PHASE3Not yet recruiting
270 participants
Started: Jan 17, 2025 · Completed: Mar 10, 2027
1 condition1 sponsor0 locations
NCT06778967
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus
PHASE3Not yet recruiting
1,100 participants
Started: Jan 7, 2025 · Completed: Dec 11, 2026
1 condition1 sponsor0 locations
NCT06728124
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Subjects
PHASE3Not yet recruiting
630 participants
Started: Dec 31, 2024 · Completed: May 31, 2026
1 condition1 sponsor0 locations
NCT06780410
A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid
PHASE3Recruiting
240 participants
Started: Dec 20, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location